Therapy Goals in IBD: How good is good enough?

During the 9^th Swiss IBD Roadshow supported by AbbVie, Prof. Dr. med. Axel Dignass, Agaplesion Markus Hospital, Goethe University in Frankfurt am Main, discussed the new STRIDE II recommendations for the treatment of Crohn’s Disease and Ulcerative Colitis and talked about current therapeutic goals and strategies. Please watch the highlights of his presentation in the following video!